plexes that are reactive to anti-SOD antibody and resisthe progression of disease etiology, we performed a tant to SDS denaturation. In the presence of the proteascreen for small molecules that disrupt aggresome some inhibitor ALLN, these complexes are formed much formation in cultured cells. After screening 20,000 faster (Supplemental Figure S1B ). WTSOD-GFP does compounds, we obtained two groups of compounds not form similar complexes ( Figure 1B ). that specifically prevented aggresome formation. One
. Our findings suggest tin antibody [7] . These data convinced us that mSODa connection between HDAC activity and aggresome GFP is a reasonable model to study mSOD aggregation. formation and also lay the groundwork for a direct test
We concluded from these data that mSOD-GFP is of the role of aggresome formation in ALS etiology.
less stable than WTSOD-GFP. It tends to precipitate and readily forms aggresomes in COS1 cells upon inhibiResults and Discussion tion of the protein degradation machinery. We developed a high throughput assay based on this observation Mutant SOD-GFP, but Not Wild-Type SOD-GFP, to screen for compounds that disrupt aggresome forForms Aggresomes in COS1 Cells mation. Mutations in the cytoplasmic metalloenzyme Cu/Zn superoxide dismutase 1 (SOD1) cause about 20% of familial ALS [1, 5] . Mutant SOD1 forms aggresome-like struc-
Several Groups of Compounds Inhibit tures in patients, tissue culture cells, and animal models Aggresome Formation of ALS [2, 6-8]. To develop an assay for aggresome
To find small molecules that inhibit aggresome formaassembly for screening small molecules, we generated tion, we developed a screening protocol using COS1 adenoviruses expressing mutant (A4V, G85R, and G93A) cells infected with adenovirus expressing G85RSOD-and wild-type (WT)SOD-GFP fusion proteins and ex-
GFP (see Supplemental Data). pressed them in COS1 cells. WTSOD-GFP-expressing
After screening 20,000 compounds, we identified 25 cells showed diffuse, uniform cytoplasmic fluorescence compounds that reproducibly inhibited aggresome forthat was little affected by adding proteasome inhibitors. mation. Subsequent testing allowed us to group the Cells expressing mSOD-GFP, in contrast, showed granscreening positives into three categories: microtubule ular fluorescence, and some showed aggresome formainhibitors (9), protein synthesis inhibitors (4), and candidate-specific aggresome inhibitors (12) (Figure 2 ). Microtubule inhibitors were detected by examining micro-*Correspondence: ching_liu@hms.harvard.edu Figure 2E ). Only the specific inhibitors, those whose activity could not be explained by effects on microtu- Figure S2B ). We tested the potent HDAC inhibitors Trichostatin A and Trapoxin [9] . These have a similar effect bules or protein synthesis, were pursued further. These fell into two groups. The first group is composed of at concentrations of 1 M and 10 nM, respectively, but
In cells treated with Scriptaid or DPD, the level of mSOD-GFP is enhanced compared with that in untreated cells ( Figures 2G and 2H) , presumably due to enhanced transcription from the CMV promoter. We considered the possibility that the effect of these compounds is due to enhanced expression of SOD-GFP overwhelming the aggresome assembly pathway. To test this, we compared the percentage of cells containing aggresomes at different protein expression levels. Total GFP signal per cell was measured and the cells were assigned to a high or low expression group Deacetylase enzymes can be either cytoplasmic (e.g., tubulin deacetylase) or nuclear (e.g., histone deacetylase). We found that both Scriptaid and Trichostatin A inhibited deacetylation of both histones (H3, H4) and tubulin, indicating that they are a relatively broad inhibitors of deacetylases, but DPD did not, indicating that it is probably not an HDAC inhibitor (data not shown). A tubulin-specific deacetylase inhibitor Tubacin [15] had no effect at concentrations that are selective for tubulin acetylation (data not shown). These data suggest that the effect of Scriptaid might require inhibition of histone deacetylation, consistent with this notion; the effect of Scriptaid and DPD required transcription (Supplemental Figure S3) .
We hypothesize that Scriptaid and DPD act through a transcription program that changes the expression profile of some protein factor(s) that are involved in the underway to test these compounds in ALS transgenic mice. In response to various physiological stresses, includWhile this manuscript was under review, a study used ing heat shock or exposure to toxic agents, cells upreggenetics to show that the catalytic activity of histone ulate a conserved set of heat shock proteins via trandeacetylase HDAC6 was required for aggresome formascriptional regulation of the corresponding genes [13] .
tion [16] . In this study, the authors provided evidence Misfolded proteins are competent to mediate a subset that HDAC6 binds directly to both misfolded protein and of the responses to heat shock in Saccharomyces cerethe dynein/dynactin transport machinery. Our results visiae [14] . Previous studies showed that in NIH 3T3 are consistent with their conclusion, and in addition, this cells stably expressing a mutant form of SOD, the level of study provides small molecule tools for further disHsp70 is upregulated [12] . We did not see any significant secting the aggresome pathway. change in the level of Hsp70 and Hsp90 proteins. However, we did notice that expression of mSOD-GFP 
